There are 2949 resources available
Dissecting the clinical data for PARP inhibitors in metastatic castrate resistant prostate cancer
Presenter: Joaquin Mateo
Session: AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Resources:
Webcast
Considerations for the approach to HRRm testing in prostate cancer
Presenter: Alexander Wyatt
Session: AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Resources:
Webcast
Panel discussion
Presenter: Alexander Wyatt
Session: AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Resources:
Webcast
Summary and meeting close
Presenter: Neal Shore
Session: AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Resources:
Webcast
Welcome and introduction
Presenter: Cristina Suarez
Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion
Resources:
Webcast
Shifting perceptions in the first-line treatment of aRCC & Panel discussion
Presenter: Toni Choueiri
Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion
Resources:
Webcast
Personalizing treatment approaches in clinical practice. Part 1: Sequencing of treatment in aRCC following progression & Panel discussion
Presenter: Camillo Guglielmo Porta
Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion
Resources:
Webcast
Personalizing treatment approaches in clinical practice. Part 2: Understanding the patient experience of aRCC & Panel discussion
Presenter: Howard Gurney
Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion
Resources:
Webcast
Closing comments
Presenter: Cristina Suarez Rodriguez
Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion
Resources:
Webcast
Welcome and introductions
Presenter: Eva Ciruelos
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast